AJANTPHARM Share Price Performance
₹0
-2482.30 (-100.00%)
Price ₹0
Fair Value₹3,742.00
Share Pricen/a
Narrative Update • May 09
Ajanta Pharma Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
AJANTPHARM Community Narratives
AN
Fair Value
·Fair Value ₹3.74k 18.1% undervalued intrinsic discount
Expanding Asian And African Markets Will Drive Secular Growth
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value ₹3.21k 4.5% undervalued intrinsic discount
Aging Demographics And Emerging Markets Will Fuel Global Healthcare Demand
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
Fair Value
·Fair Value ₹2.61k 17.6% overvalued intrinsic discount
Tightening Global Regulations And Supply Risks Will Drag Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Expanding Asian And African Markets Will Drive Secular Growth
Key Takeaways Aggressive investment in new markets, products, and digital infrastructure positions Ajanta for sustained above-industry growth and improved profitability across Asia and Africa. First-mover advantage in chronic and specialty therapeutics, coupled with rising global demand for generics, underpins margin expansion and robust long-term cash flow.Read more
AN
₹3.74k
18.1% undervalued intrinsic discount
Fair Value
Revenue
12.91% p.a.
Profit Margin
20.37%
Future PE
39.44x
Price in 2029
₹5.3k
Tightening Global Regulations And Supply Risks Will Drag Outlook
Key Takeaways Rising regulatory scrutiny, supply chain risks, and pricing pressures threaten Ajanta Pharma's margins and revenue growth, particularly in emerging and US markets. Heavy dependence on emerging markets and a limited pipeline in complex drugs expose the company to volatility, intense competition, and restricted long-term profit expansion.Read more
AN
₹2.61k
17.6% overvalued intrinsic discount
Fair Value
Revenue
12.12% p.a.
Profit Margin
20.84%
Future PE
29.61x
Price in 2029
₹3.68k
Aging Demographics And Emerging Markets Will Fuel Global Healthcare Demand
Key Takeaways Focus on high-demand therapeutic segments and expansion into emerging markets positions Ajanta Pharma for sustained growth and increased market share. Robust R&D pipeline, manufacturing expansion, and strong financial discipline provide a solid foundation for margin improvement and future growth opportunities.Read more
AN
₹3.21k
4.5% undervalued intrinsic discount
Fair Value
Revenue
12.75% p.a.
Profit Margin
21.25%
Future PE
35.16x
Price in 2029
₹4.54k
Trending Discussion
Recently Updated Narratives
AN
AJANTPHARM: Audit Oversight And Refined Assumptions Will Support Future Returns
Fair Value: ₹3.74k 18.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AJANTPHARM: Overseas Expansion And Ireland Subsidiary Will Likely Cap Future Upside
Fair Value: ₹2.61k 17.6% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AJANTPHARM: Fair Outlook Will Depend On New International Licensing And Subsidiary Expansion
Fair Value: ₹3.21k 4.5% undervalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Ajanta Pharma Limited Key Details
About AJANTPHARM
- Founded
- 1973
- Employees
- 9628
- CEO
- WebsiteView website
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.
